Altitude Lab startups raise $205M+, advancing biotech innovation in Salt Lake City despite tough funding.

Altitude Lab's portfolio companies have raised over $205 million in early-stage funding since 2020, marking significant progress in Salt Lake City's biotech scene. Key startups like Peel Therapeutics and Rebel Medicine have advanced clinical trials and secured Series A funding, driving innovation in cancer treatment and non-opioid pain relief. Partnerships and new technologies from companies such as Leash Bio and 3Helix highlight the growing ecosystem. Altitude Lab continues to strengthen its leadership and mission to build a national biotech hub in the Mountain West region.